GW0742
GW0742 (also known as GW610742 and fitorine) is a PPARδ/β agonist that has been investigated for drug use by GlaxoSmithKline.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
GW0742 (also known as GW610742 and fitorine) is a PPARδ/β agonist that has been investigated for drug use by GlaxoSmithKline.
Pharmacodynamics
It is mixed PPAR-B agonist antagonist depending on its dosage. It has weak activity on multiple nuclear receptors as well. It is antagonistic at androgen receptors and VDR. In silico modelling suggest that it has effects on thyroid hormone receptors.
Derivatives
Multiple derivatives of GW0742 core structure have been developed. One of the compounds has the thiazole ring replaced with an oxazole ring inhibited VDR-meditated transcription with IC 50 of 660 nM. Other novel analogues which are more potent than GWO742 with reduced toxicity have been developed as well.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370308562 under CC BY-SA 4.0; modifications have been made.